Position in BIO
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$280,103
+$34,525 QoQ
Shares Held
954
+8.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#243
of 399 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $23,001,271 across 9 Medical Devices names. BIO ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
60,357 | $19,002,797 | |
| 2 | ABT |
Abbott Laboratories
|
10,837 | $983,349 | |
| 3 | MDT |
Medtronic plc
|
9,799 | $766,575 | |
| 4 | EW |
Edwards Lifesciences Corp
|
7,726 | $698,893 | |
| 5 | BSX |
Boston Scientific Corp
|
9,249 | $394,747 | |
| 6 | DXCM |
Dexcom Inc
|
5,213 | $351,095 | |
| 7 | PHG |
Koninklijke Philips NV
|
11,642 | $316,545 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
954 | $280,103 |
All Filings in BIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,103 | 954 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $245,578 | 881 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $199,973 | 660 | Shares | Sole | 2026-03-04 | |
| No filing history on record for this holder in this stock. | ||||||